Biotech company Moderna experienced a 15% drop in the last three days, its lowest value for the month of December. Since posting its all-time high stock price on December 1st, Moderna shares have declined by a margin of 30%.
This decline looks to be the result of sales spurred by...
The major US stock indexes finished higher at a premature close on Thursday prior to the Christmas weekend. While the S&P finished the week slightly lower, The Dow Jones managed a slight gain while Nasdaq made a significant stride.
Many investors had high hopes due to the possibility of a...
Wednesday’s bidding on the 5G wireless spectrum became the telecom industry’s most expensive auction ever, with nearly $70 billion being spent as leading telecom companies compete for airspace on the new network.
Analysts predict that AT&T, Charter Communications, Comcast, T-Mobile US, and Verizon Communications are among the leading bidders. While...
With traders expressing optimism as impending government aid is expected to fuel economic growth, U.S. stocks have been edging ever closer to record high figures. This positive reaction has offset the initial uncertainty surrounding the speed with which vaccines can be expected to be distributed.
The S&P 500 index is...
Following reports of the New York Stock Exchange deciding to remove the three largest Chinese telecom companies, Chinese oil companies look to be the next in line to be delisted. The company that’s most in the hot seat is CNOOC Ltd—and they also happen to be the biggest offshore...
Electric vehicle battery manufacturer QuantumScape endured a difficult start to trading in 2021, with its stock falling by an astronomical 41% on January 4th. Several reasons have been given for this steep decline, ranging from the company’s filing known as a Resale S-1 form on December 31st to the...
While Moderna continues to wait for the European Commission’s decision on whether or not to approve the use of its vaccine within European Union member states, the biotech firm received a monumental boost as the European Medicines Agency (EMA) recommended that Moderna’s vaccine be authorized for use.
EMA executive director...
Johnson & Johnson stocks slid by 0.2% during afternoon trading on Wednesday after reports of its coronavirus vaccine candidate falling two months behind schedule.
While the pharmaceutical company had initially planned to have 12 million doses of its vaccine ready for distribution by the end of February, several delays have...
Following positive reports regarding the development of coronavirus vaccine candidates by the likes of Pfizer and Moderna, oil stocks have risen to their highest levels since early September. Futures, in particular, enjoyed a significant rise of 2.5% on Wednesday.
The surge in share prices mostly came as a result of...
AstraZeneca and Moderna are among the array of healthcare providers whose coronavirus vaccines are expected to be approved by the World Health Organization in the coming weeks, Reuters revealed in a recent report.
Moderna's vaccine, which is already in use in the United States and certain overseas countries, is expected...